Elsemieke de Vries

515 total citations
9 papers, 342 citations indexed

About

Elsemieke de Vries is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Elsemieke de Vries has authored 9 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Hepatology and 2 papers in Oncology. Recurrent topics in Elsemieke de Vries's work include Liver Diseases and Immunity (4 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Drug Transport and Resistance Mechanisms (2 papers). Elsemieke de Vries is often cited by papers focused on Liver Diseases and Immunity (4 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Drug Transport and Resistance Mechanisms (2 papers). Elsemieke de Vries collaborates with scholars based in Netherlands, Denmark and Italy. Elsemieke de Vries's co-authors include Ulrich Beuers, Nahid Mostafavi, Joost P.H. Drenth, Jef Verbeek, Karel van Erpecum, Jorn Goet, Albert Parés, Ronald Oude Elferink, Frans van der Heide and K. van Nieuwkerk and has published in prestigious journals such as Gastroenterology, PEDIATRICS and Journal of Hepatology.

In The Last Decade

Elsemieke de Vries

9 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elsemieke de Vries Netherlands 7 179 160 156 102 43 9 342
Gustavo Varela‐Fascinetto Mexico 12 123 0.7× 240 1.5× 164 1.1× 81 0.8× 21 0.5× 46 457
R. Lorho France 11 257 1.4× 269 1.7× 101 0.6× 44 0.4× 48 1.1× 18 534
Wanrong Yin United States 11 87 0.5× 164 1.0× 87 0.6× 51 0.5× 12 0.3× 11 388
Magdalena Salcedo Spain 13 301 1.7× 243 1.5× 226 1.4× 51 0.5× 11 0.3× 43 508
Amine Benmassaoud Canada 13 230 1.3× 122 0.8× 284 1.8× 26 0.3× 13 0.3× 38 433
Gloria Sánchez‐Antolín Spain 12 212 1.2× 220 1.4× 181 1.2× 41 0.4× 21 0.5× 62 454
D Kahn South Africa 14 310 1.7× 352 2.2× 119 0.8× 24 0.2× 16 0.4× 54 571
Jeremy Rajanayagam Australia 8 199 1.1× 154 1.0× 162 1.0× 16 0.2× 12 0.3× 15 391
Doris H. Toro Puerto Rico 9 285 1.6× 96 0.6× 346 2.2× 42 0.4× 6 0.1× 48 504
Fátima Aparecida Ferreira Figueiredo Brazil 12 252 1.4× 121 0.8× 316 2.0× 141 1.4× 77 1.8× 23 530

Countries citing papers authored by Elsemieke de Vries

Since Specialization
Citations

This map shows the geographic impact of Elsemieke de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsemieke de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsemieke de Vries more than expected).

Fields of papers citing papers by Elsemieke de Vries

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsemieke de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsemieke de Vries. The network helps show where Elsemieke de Vries may publish in the future.

Co-authorship network of co-authors of Elsemieke de Vries

This figure shows the co-authorship network connecting the top 25 collaborators of Elsemieke de Vries. A scholar is included among the top collaborators of Elsemieke de Vries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsemieke de Vries. Elsemieke de Vries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Vries, Elsemieke de, Lowiek M. Hubers, Nahid Mostafavi, et al.. (2020). IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer. JHEP Reports. 2(4). 100116–100116. 10 indexed citations
2.
Vries, Elsemieke de, Ruth Bolier, Jorn Goet, et al.. (2020). Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial. Gastroenterology. 160(3). 734–743.e6. 130 indexed citations
3.
Vries, Elsemieke de, R. Bart Takkenberg, Nahid Mostafavi, et al.. (2020). Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma. Liver International. 40(12). 3042–3050. 23 indexed citations
4.
Vries, Elsemieke de & Ulrich Beuers. (2019). Ursodeoxycholic acid in pregnancy?. Journal of Hepatology. 71(6). 1237–1245. 26 indexed citations
5.
Vries, Elsemieke de & Ulrich Beuers. (2017). Management of cholestatic disease in 2017. Liver International. 37(S1). 123–129. 67 indexed citations
6.
Esch, Aura A. J. van, Elsemieke de Vries, René H. M. te Morsche, et al.. (2011). Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis.. PubMed. 69(7). 330–4. 6 indexed citations
7.
Vries, Elsemieke de, et al.. (2010). Hydrolysed Formula Is a Risk Factor for Vitamin K Deficiency in Infants With Unrecognised Cholestasis. Journal of Pediatric Gastroenterology and Nutrition. 51(6). 773–776. 3 indexed citations
8.
Hasselt, Peter M. van, Tom J. de Koning, Nina Kvist, et al.. (2008). Prevention of Vitamin K Deficiency Bleeding in Breastfed Infants: Lessons From the Dutch and Danish Biliary Atresia Registries. PEDIATRICS. 121(4). e857–e863. 51 indexed citations
9.
Bruisten, Sylvia M., P. H. J. Frissen, Peter van Swieten, et al.. (1997). Prospective Longitudinal Analysis of Viral Load and Surrogate Markers in Relation to Clinical Progression in HIV Type 1-Infected Persons. AIDS Research and Human Retroviruses. 13(4). 327–335. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026